New hope for Parkinson's psychosis: drug trial shows promise
NCT ID NCT06068465
First seen Feb 28, 2026 · Last updated May 21, 2026 · Updated 8 times
Summary
This study tested a drug called pimavanserin to see if it can safely reduce hallucinations and delusions in people with Parkinson's disease. About 248 adults with Parkinson's and related psychosis took either the drug or a placebo for 43 days. The main goal was to measure changes in their psychotic symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE PSYCHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Hospital
Beijing, Beijing Municipality, 100005, China
-
Guangdong Provincial Peoples Hospital
Guangzhou, Guangdong, 510000, China
-
Huai'an Second People's Hospital
Huaian, Jiangsu, 223022, China
-
Inner Mongolia Autonomous Region People's Hospital
Hohhot, Inner Mongolia, 010000, China
-
Mianyang Central Hospital
Mianyang, Sichuan, 621099, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
-
Peking University Sixth Hospital
Beijing, Beijing Municipality, 100191, China
-
People's Hospital of Ningxia Hui Autonomous Region
Yinchuan, Ningxia, 750002, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
-
Qilu Hospital of Shandong University(Qingdao)
Qingdao, Shandong, 266035, China
-
Ruijin Hospital
Shanghai, Shanghai Municipality, 200025, China
-
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, 550001, China
-
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, 221004, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230061, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, 350005, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
-
The First Hospital of China Medical University
Shenyang, Liaoning, 110002, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330008, China
-
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215004, China
-
The Second Hospital of HeBei Medical University
Shijiazhuang, Hebei, 050005, China
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
-
Tianjin Huanhu Hospital
Tianjin, Tianjin Municipality, 300222, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
-
Xuan Wu Hospital
Beijing, Beijing Municipality, 100053, China
-
Zhongda Hospital Southeast University
Nanjing, Jiangsu, 210009, China
Conditions
Explore the condition pages connected to this study.